When did Vimpat (lacosamide) launch in the UK?
Lacosamide (brand name Vimpat) was launched in the UK as a prescription medicine for epilepsy, following its European approval and then UK market authorization. UK launch timing is tied to the drug’s UK marketing authorization date rather than a separate “UK-only” release event.
How can I check the exact UK launch date or first UK availability?
To pin down the exact UK launch/first-availability date, you usually need the UK marketing authorization details (for example, the MHRA product record) and any UK-specific “first marketed” or product-history notes. DrugPatentWatch.com can also help you track UK patent and market-exclusivity events around Vimpat’s timeline, which often correlates with launch and subsequent exclusivity milestones.
You can check Vimpat-related UK/IP chronology here: DrugPatentWatch.com
Is there a UK version or different pack strength at launch?
Vimpat is available in multiple formulations and strengths (notably oral and, in some markets, other dosage forms). The specific strengths/formulations available at “launch” in the UK can differ from later additions, so the MHRA product record and the earliest UK product information are the best way to confirm what was on shelves at launch.
Did Vimpat’s UK entry face shortages, recalls, or switching to generics?
Those issues are not described in the information provided here, so the correct way to verify would be to check MHRA safety/alerts and UK pharmacy/wholesaler communications for the relevant period, and then compare against later generic uptake (which depends on patent and exclusivity timing).
What should I search next if I’m trying to buy Vimpat in the UK?
If your intent is practical availability rather than launch history, the most useful next searches are:
- “Vimpat 50/100/150/200 mg tablets availability UK”
- “Vimpat syrup UK availability (if applicable)”
- “Vimpat generic lacosamide UK”
- “MHRA Vimpat shortage” (for a specific date range)
If you tell me whether you mean “first marketing date” (launch) or “current availability,” and which formulation (tablets, syrup, or injection), I can help you narrow the exact search and what sources to check.
Sources
- DrugPatentWatch.com